Purchases and Sales Made in Q4 2024 in Lexaria Bioscience Corp. (LEXX)
This table provides information about the institutional ownership of Lexaria Bioscience Corp. (LEXX) during Q4 2024. The information is specifically focused on institutions that hold shares of Lexaria Bioscience Corp..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Armistice Capital, LLC
New York, NY |
BUY
|
- |
460KNew |
$925K - $1.52M
|
460K
$791K
|
|
|
Feb 06, 2025
Q4 2024
|
Raymond James Financial Inc
St. Petersburg, FL |
BUY
|
- |
60.6KNew |
$122K - $200K
|
60.6K
$104K
|
|
|
Feb 11, 2025
Q4 2024
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
18.4K+ 16.89% |
$37K - $60.8K
|
127K
$219K
|
|
|
Feb 12, 2025
Q4 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
16.3K+ 10.83% |
$32.7K - $53.8K
|
167K
$287K
|
|
|
Mar 17, 2025
Q4 2024
|
Wealth Enhancement Advisory Services, LLC
|
BUY
|
- |
15.1K+ 108.88% |
$30.3K - $49.7K
|
28.9K
$49.7K
|
|
|
Jan 28, 2025
Q4 2024
|
Byrne Asset Management LLC
|
BUY
|
- |
13KNew |
$26.1K - $42.9K
|
13K
$22.4K
|
|
|
Feb 13, 2025
Q4 2024
|
Scotia Capital Inc.
|
BUY
|
- |
10KNew |
$20.1K - $33K
|
10K
$17.2K
|
|
|
Feb 07, 2025
Q4 2024
|
High Tower Advisors, LLC
Chicago, IL |
BUY
|
- |
8K+ 61.43% |
$16.1K - $26.4K
|
21K
$36.2K
|
|
|
Jan 22, 2025
Q4 2024
|
R Squared LTD
Central, K3 |
BUY
|
- |
2.62KNew |
$5.27K - $8.65K
|
2.62K
$4.51K
|
|
|
Feb 12, 2025
Q4 2024
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
1.5K+ 60.0% |
$3.01K - $4.95K
|
4K
$6.88K
|
|
|
Feb 13, 2025
Q4 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
738+ 54.91% |
$1.48K - $2.44K
|
2.08K
$3.58K
|
|
|
Feb 14, 2025
Q4 2024
|
Ubs Group Ag
|
BUY
|
- |
116New |
$233 - $383
|
116
$200
|
|
|
Feb 14, 2025
Q4 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
11+ 9.57% |
$22.1 - $36.3
|
126
$217
|
|
|
Feb 13, 2025
Q4 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-2.75K- 11.98% |
$5.53K - $9.08K
|
20.2K
$34.8K
|
|
|
Feb 14, 2025
Q4 2024
|
Invenomic Capital Management LP
Boston, MA |
SELL
|
- |
-65K- 13.67% |
$131K - $215K
|
411K
$706K
|